PTC258

N/A

Report date: 2023/02/22 10:03:44
NME

Base Information

Drug NamePTC258
Drug Alias NamePTC258PTC-258
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionElongator complex protein 1 modulators
TargetsElongator complex protein 1
Therapy Area/IndicationsPrimary Dysautonomias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPrimary Dysautonomias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A